$RAD Optimists Not Wrong This Time on Rite Aid Shares of

New Post Public Reply Private Reply Replies (0) Message Board
Hounddog

$RAD Optimists Not Wrong This Time on Rite Aid

Shares of Rite Aid Corp. RAD -0.64%are up sharply in 2013, as investors bet that the pharmacy chain can emerge from its multiyear profit slump. This year's 130% gain is faster than those of nearly 60% in the first half of both 2011 and 2012.

Will the company be able to hang on to the gains this time?

On face value, the change in Rite Aid's fortunes is good but not striking. After 21 quarters in a row of losses, the company is expected to report its third consecutive set of positive earnings per share on Thursday. Analysts polled by FactSet predict a profit of nine cents a share in the period through May, compared with a loss of three cents a year earlier.
That sort of swing wouldn't normally justify an incremental $1.80 on a company's share price in just six months unless there is the promise of plenty more to come, and soon.

On valuation alone though, Rite Aid may deserve the benefit of the doubt.

Any comparison with peers has to take Rite Aid's bloated balance sheet into account. Rite Aid's valuation multiple of debt-adjusted market value to revenue of just 0.35 times is only half that of CVS Caremark Corp. CVS -1.37%and Walgreen Co. WAG -1.32%
Rite Aid's debt-to-asset ratio of 85% also is about six times that of its two rivals, a legacy of large acquisitions made just before the financial crisis. The company's recent efforts to retire high-interest borrowings may speed its earnings recovery.

The environment for all drugstores has been tough. They are losing lucrative "front of store" business to discounters such as Dollar General Corp. DG -1.84%and face heightened competition filling prescriptions from supermarkets and national nondrug chains such as Wal-Mart Stores Inc. WMT -1.68%and Costco Wholesale Corp. COST -1.69%
The news isn't all bad, though. Pharmacies are adding services such as clinics and are turning to more profitable store formats. And a shift to generic prescriptions has depressed sales but helped margins.

The more Rite Aid whittles away at its debt-servicing costs, the more it will be able to invest and keep pace with peers as the sector tries to reinvent itself.

Even after its recent rally, Rite Aid has by far the most potential in a sector struggling to find its footing.
http://online.wsj.com/article/ahead_of_the_tape.html

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Digital Health Excellence: 14 Systems Earn Top Honors

Updated Category News Views 6

The pace at which healthcare is embracing digital transformation makes one's head spin these days. Fourteen organizations just hit the jackpot of sorts—the 2026 CHIME Digital Health Most Wired survey awarded them the highest honor, Level 10. This ain't just some participation trophy; it's the real deal, putting a spotlight on organizations that aren't merely dabbling in...

Continue Reading
Dehua County Revamps Ceramic Heritage for Global Stage

Updated Category News Views 2

Dehua's Ceramic Legacy Hits the Reset Button Alright, picture this: Dehua County in southeast China's Fujian Province has spent thirty years turning its age-old ceramic craft into a heavyweight industry. Now, it's giving that legacy a 21st-century makeover, aligning it with fashion, branding, and the global scene. This isn't just for kicks—it's a serious push fueled by...

Continue Reading
NJ Roads Spark Emmy Nod: A Public Affairs Win

Updated Category News Views 4

Our Infrastructure Gets Its Due Sometimes, the real unsung heroes aren’t the ones under bright lights but those toiling under the sun. “Our Infrastructure Matters,” a TV and web program taking a hard-nosed look at what's keeping our roads from crumbling under the weight of millions, just landed its first-ever New York Emmy nomination. Yep, you heard it right. No,...

Continue Reading
Sunrate and TourMind Partner to Boost Travel Payments

Updated Category News Views 13

Travel Sector Eyes Major Payment Makeover Sunrate and TourMind are shaking hands in a big way, capitalizing on the blurring lines between digital connectivity and global travel demands. Their union is the latest bid to tackle financial snags and streamline operations in this ever-evolving market. I mean, who isn't fed up with clunky payment systems when jet-setting across...

Continue Reading
SAGA Metals Strikes Potential with Wolverine Drilling Program

Updated Category News Views 1

Drilling for Treasure in Labrador's Rich Earth Hey, ever felt that gritty thrill in your bones? That's what I imagine SAGA Metals must be feeling right now. When you're out there punching holes into Mother Earth hoping to hit pay dirt, and every single one of those holes hits something juicy—trust me, that's like hitting the jackpot before even knowing the lottery...

Continue Reading
WF Holding Cancels Additional Purchase Rights in Deal

Updated Category News Views 4

WF Holding Calls Off Extra Purchase Rights Well, someone's decided to hit the brakes over at WF Holding Limited (NASDAQ:WFF). They're pulling the plug on an extra purchase gravy train they’d previously left open for investors. Straight from Kuala Lumpur, WF Holding's been in the fiberglass plastic game for over three decades, pushing out a product line that's almost as...

Continue Reading
NEXT Properties' Exchange Offer Sees Strong Participation

Updated Category News Views 7

NEXT Properties Makes Bold Moves with Exchange Offers NEXT Properties has pulled the trigger on a massive swap of its notes, and it's a tale investors should tune into. They're swapping out their old notes like a veteran trader ditching penny stocks for blue chips. It’s an intriguing maneuver—risk-laden yet foreboding to anyone who knows the game. Breaking Down the...

Continue Reading
Gildan Faces Heat: Channel Stuffing Allegations Arise

Updated Category News Views 10

Gildan's Stocks Take a Dive Amid Allegations Just when you thought the market swings were calming down, Gildan Activewear Inc. (NYSE: GIL) lands in hot water, sending investors scrambling. The spotlight's on them, thanks to some eye-catching accusations from Jehoshaphat Research. The word on the street is Gildan's been engaging in some questionable financial gymnastics...

Continue Reading
DaVita's Stand on HHS Kidney Plan: Innovation at Core

Updated Category News Views 10

DaVita Stands Firm on Kidney Care Innovation The healthcare landscape's shifting undercurrent, folks, and kidney care has landed smack in the spotlight with the U.S. Department of Health and Human Services (HHS) putting forth its Kidney Care National Plan. Now, this isn't some bureaucratic mumbo-jumbo—this plan's setting the tone for kidney disease treatment across...

Continue Reading
Ellevio Bolsters Stockholm Grid with SEK 1B NIB Loan

Updated Category News Views 6

In a move that packs plenty of juice for Stockholm's energy needs, Ellevio has shaken hands with the Nordic Investment Bank (NIB) in a hefty SEK 1 billion loan agreement. This isn’t just some pocket change—this financing is a ticket to revamping and beefing up the Beckomberga substation, a project hailed for fortifying the regional electricity grid in the Swedish...

Continue Reading

Top 5 Most Recently Viewed Articles

Navigating the Financial Future: Insights for 2025 Retirement Planning

Updated Category News Views 321

Current Challenges for Retirement Savers and Business Owners As we step into 2025, American workers and small business owners face significant uncertainty. Such concerns arise from ongoing inflationary pressures and high interest rates that linger in the economy. With a new presidential administration in place, changes in policy also play a pivotal role in shaping the...

Continue Reading
Innovative Insights into Premature Ejaculation Treatment Growth

Updated Category News Views 135

The Transformation of the Premature Ejaculation Treatment Market The global market for premature ejaculation treatment is undergoing a significant transformation, projected to experience growth of USD 1.53 billion between 2025 and 2029. This trend highlights the robust expansion that comes with the growing awareness and demand for effective treatment options. Various...

Continue Reading
Peachtree Group Achieves Milestone with $1 Billion CPACE Financing

Updated Category News Views 241

Peachtree Group Reaches a Significant Financial Milestone Peachtree Group has made waves in the financial landscape with a remarkable achievement, crossing the $1 billion threshold in Commercial Property Assessed Clean Energy (CPACE) financing. This impressive feat places Peachtree among a select group of industry leaders, showcasing its commitment and innovative approach...

Continue Reading
Leads Biolabs Continues Innovative Trials for Advanced Melanoma

Updated Category News Views 215

Breakthrough in Melanoma Treatment: First Patient Dosed Leads Biolabs Co., Ltd. is excited to announce a significant milestone in the fight against advanced melanoma, as the first patient has been successfully dosed in a pivotal Phase 1b/II clinical trial evaluating Opamtistomig. This new treatment has shown a lot of promise as a PD-L1/4-1BB bispecific antibody aimed at...

Continue Reading
Investigating Financial Issues at Simulations Plus: What Investors Need to Know

Updated Category News Views 174

Understanding the Investigation of Simulations Plus In light of recent developments, an investigation is underway regarding the financial practices of Simulations Plus, Inc. (NASDAQ: SLP). Concerns have emerged related to potential violations of federal securities laws that may have impacted investors significantly. This investigation, initiated by legal representatives,...

Continue Reading